Advancements in Topical Antifungal Vehicles

22. NAFTIN (naftifine hydrochloride) Gel, 2% Prescribing information. Merz Pharmaceuticals, LLC. 2013; Rev 6/13.
23. NAFTIN (naftifine hydrochloride) Cream, 2% Prescribing information. Merz Pharmaceuticals, LLC. 2009; Rev 1/12.
24. Stein, Gold L, Vlahovic T, Verms A, et al. Naftifine Hydrochloride Gel 2% An effective topical treatment for moccasin typoe tinea pedis. JDrugs in Dermatol. 2015; 14(10):1138-1144
25. Erdal MS, Peköz AY, Aksu B, Araman A. Impacts of chemical enhancers on skin permeation and deposition of terbinafine. Pharm Dev Technol. 2014; 19(5):565-70.
26. Pillai AB, Nair JV, Gupta NK, Gupta S. Microemulsion-loaded hydrogel formulation of butenafine hydrochloride for improved topical delivery. Arch Dermatol Res. 2015 May 26. [Epub ahead of print]
27. Koga H, Nanjoh Y, Inoue K, et al. ISHAM June 2006. P-0090
28. Jarratt M, Jones T, Adelglass J, et al. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle- controlled study. J Drugs Dermatol. 2014; 13(7):838-46.
29. Susilo R, Korting HC, Strauss UP, et al. Rate and extent of percutaneous absorption of sertaconazole nitrate after topical administration. Arzneimittelforschung. 2005; 55(6):338-42.
30. Bikowski J. Practical features and clinical applications of a non-steroidal anti-inflammatory foam. Pract Dermatol. 2009:69-71.
31. Elewski BE, Vlahovic TC. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials. J Drugs Dermatol. 2014;13(7):803-8.

AUTHOR CORRESPONDENCE